References
- Teesson M, Slade T, Mills K. Comorbidity in Australia: findings of the 2007 National Survey of mental health and wellbeing. Aust N Z J Psychiatry. 2009;43(7):606–614.
- AIHW. Co-morbidity of mental disorders and physical conditions 2007. Canberra: Australian Institute of Health and Welfare; 2012.
- Moussavi S, Chatterji S, Verdes E, et al. Depression, chronic diseases, and decrements in health: results from the World Health Surveys. The Lancet. 2007;370(9590):851–858.
- Fortin M, Bravo G, Hudon C, et al. Psychological distress and multimorbidity in primary care. Ann Fam Med. 2006;4(5):417–422.
- Wolff J, Heister J, Normann C, et al. Hospital costs associated with psychiatric comorbidities: a retrospective study. BMC Health Serv Res. 2018;18(1):67.
- Clarke D, Depression CK. Anxiety and their relationship with chronic diseases: a review of the epidemiology, risk and treatment evidence. Med J Aust. 2009;190(S7):S54–S60.
- Hunter EG, Toombs M. Mental health among Indigenous Australians. Oxford: Oxford University Press; 2013. (Indigenous Australians and Health: The Wombat in the Room).
- Parker R. Australia’s aboriginal population and mental health. J Nerv Ment Dis. 2010;198(1):3–7.
- Nasir BF, Toombs MR, Kondalsamy-Chennakesavan S, et al. Common mental disorders among Indigenous people living in regional, remote and metropolitan Australia: a cross-sectional study. BMJ Open. 2018;8(6):e020196.
- AIHW. Australian burden of disease study: impact and causes of illness and death in Australia 2015. Canberra: Australian Institute of Health and Welfare; 2019.
- Almeida O, Flicker L, Fenner S, et al. The kimberley assessment of depression of older indigenous australians: prevalence of depressive disorders, risk factors and validation of the KICA-dep scale. PLoS One. 2014;9(4):e94983–7.
- Wilhelm W, Mitchell P, Slade T, et al. Prevalence and correlates of DSM-IV major depression in an Australian national survey. J Affect Disord. 2003;75(2):155–162.
- AIHW. The health and welfare of Australia’s aboriginal and Torres strait islander people. Australia: Canberra Australian Institute of Health and Welfare; 2011.
- Lauschke VM, Ingelman-Sundberg M. The importance of patient-specific factors for hepatic drug response and toxicity. Int J Mol Sci. 2016;17(10):1714–1727.
- McMahon FJ, Insel TR. Pharmacogenomics and personalized medicine in neuropsychiatry. Neuron. 2012;74(5):773–776.
- Rae KM, Grimson S, Pringle KG. Personalised medicine: a new approach to improving health in indigenous Australian populations. Public Health Genomics. 2017;20(1):58–62.
- Pirmohamed M. Personalized pharmacogenomics: predicting efficacy and adverse drug reactions. Annu Rev Genomics Hum Genet. 2014;15:349–370.
- Turner J, Kelly B. Emotional dimensions of chronic disease. West J Med. 2000;172(2):124–128.
- Wang L, Si L, Cocker F, et al. A systematic review of cost-of-illness studies of multimorbidity. Appl Health Econ Health Policy. 2018;16(1):15–29.
- Parrish E. Comorbidity of mental illness and chronic physical illness: a diagnostic and treatment conundrum. Perspect Psychiatr Care. 2018;54(3):339–340. Jul
- AHRC. Chapter 18 Mental Health Services. Human Rights and Equal Opportunity Commission Report: Australian Human Rights Commission; 1997.
- QIMR Berghofer. Genomics partnerships: guidelines for genomic research with aboriginal and Torres Strait Islander peoples of Queensland. Brisbane, Queensland, Australia: QIMR Berghofer Medical Research Institute; 2019.
- Kowal E, Eeasteal S, Gooda M. Indigenous genomics. Australasian Sci. 2016;37(6):18–20.
- Cox AJ, Moscovis SM, Blackwell CC, et al. Cytokine gene polymorphism among Indigenous australians. Innate Immun. 2014;20(4):431–439.
- Lester S, Heatley S, Bardy P, et al. The DD genotype of the angiotensin-converting enzyme gene occurs in very low frequency in Australian aboriginals. Nephrol Dial Transplant. 1999;14(4):887–890. Apr
- Dodson M, Williamson R. Indigenous peoples and the morality of the human genome diversity project. J Med Ethics. 1999;25(2):204–208.
- Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349–357.
- O’Brien BC, Harris IB, Beckman TJ, et al. Standards for reporting qualitative research: a synthesis of recommendations. Acad Med. 2014;89(9):1245–1251.
- Salimi Ys K, Malekafzali H, Loori N, et al. Is community-based participatory research (CBPR) useful? A systematic review on papers in a decade. Int J Prev Med. 2012;3(6):386–393.
- Israel B. Methods in community-based participatory research for health. 1st ed. San Francisco, CA: Jossey-Bass; 2005.
- Morse JM, Barrett M, Mayan M, et al. Verification strategies for establishing reliability and validity in qualitative research. Int J Qual Methods. 2002;1(2):13–22.
- Kowal E. Indigenous people and genomics in Australia [conference abstract]. Twin Res Hum Genet. 2019;22(5):332.
- Kowal EE. Genetic research in Indigenous health: significant progress, substantial challenges. Med J Aust. 2012;197(1):19–20.
- Tong SY, D’Antoine H, McKinnon M, et al. Lessons learned in genetic research with indigenous Australian participants. Med J Aust. 2020;212(5):200–202.e1.
- Gracey M, King M. Indigenous health part 1: determinants and disease patterns. Lancet. 2009;374(9683):65–75.
- National Health and Medical Research Council. Road Map 3: a strategic framework for improving aboriginal and Torres Strait Islander health through research. Canberra: NHMRC; 2018.
- Beaton A, Hudson M, Milne M, et al. Engaging Māori in biobanking and genomic research: a model for biobanks to guide culturally informed governance, operational, and community engagement activities. Genet Med. 2017;19(3):345–351.
- Shaw J, Robinson R, Starks H, et al. Risk, reward, and the double-edged sword: perspectives on pharmacogenetic research and clinical testing among Alaska native people. Am J Public Health. 2013;103(12):2220–2225.